EE Student Information

The Department of Electrical Engineering supports Black Lives Matter. Read more.

• • • • •

EE Student Information, Spring Quarter through Academic Year 2020-2021: FAQs and Updated EE Course List.

Updates will be posted on this page, as well as emailed to the EE student mail list.

Please see Stanford University Health Alerts for course and travel updates.

As always, use your best judgement and consider your own and others' well-being at all times.

Workshop in Biostatistics presents "Estimation and Validation of a Class of Conditional Average Treatment Effects Using Observational Data"

Topic: 
Estimation and Validation of a Class of Conditional Average Treatment Effects Using Observational Data
Thursday, March 12, 2020 - 1:30pm
Venue: 
[remote only]
Speaker: 
Prof. Lu Tian (Stanford) and Steve Yadlowsky (Stanford EE)
Abstract / Description: 

While sample sizes in randomized clinical trials are large enough to estimate the average treatment effect well, they are often insufficient for estimation of treatment-covariate interactions critical to studying data-driven precision medicine. Observational data from real world practice may play an important role in alleviating this problem. One common approach in trials is to predict the outcome of interest with separate regression models in each treatment arm, and recommend interventions based on the contrast of the predicted outcomes. Unfortunately, this simple approach may induce spurious treatment-covariate interaction in observational studies when the regression model is misspecified. Motivated by the need of modeling the number of relapses in multiple sclerosis patients, where the ratio of relapse rates is a natural choice of the treatment effect, we propose to estimate the conditional average treatment effect (CATE) as the relative ratio of the potential outcomes, and derive a doubly robust estimator of this CATE in a semiparametric model of treatment-covariate interactions. We also provide a validation procedure to check the quality of the estimator on an independent sample. We conduct simulations to demonstrate the finite sample performance of the proposed methods, and illustrate the advantage of this approach on real data examining the treatment effect of dimethyl fumarate compared to teriflunomide in multiple sclerosis patients.

Suggested Readings available for download on program webpage:

  • "A proof-of-concept application of a novel scoring approach for personalized medicine in multiple sclerosis."
  • "Estimation and Validation of a Class of Conditional Average Treatment Effects Using Observational Data."

 

Zoom Link: https://stanford.zoom.us/j/706254400